# Study Comparing Travoprost Intraocular Implants to Timolol Ophthalmic Solution

> **NCT02754596** · PHASE2 · COMPLETED · sponsor: **Glaukos Corporation** · enrollment: 154 (actual)

## Conditions studied

- Glaucoma Open-angle

## Interventions

- **DRUG:** Travoprost Intraocular Implant, high elution
- **DRUG:** Travoprost Intraocular Implant, low elution
- **DRUG:** Timolol Maleate Ophthalmic Solution, 0.5%

## Key facts

- **NCT ID:** NCT02754596
- **Lead sponsor:** Glaukos Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-29
- **Primary completion:** 2017-08-01
- **Final completion:** 2020-07-21
- **Target enrollment:** 154 (ACTUAL)
- **Last updated:** 2023-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02754596

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02754596, "Study Comparing Travoprost Intraocular Implants to Timolol Ophthalmic Solution". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02754596. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*